Zycubo
Active substance: copper histidinate
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · COPPER HISTIDINATE 2.9 mg/1
United StatesActive
Marketing holder: Sentynl Therapeutics, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- COPPER HISTIDINATE · 2.9 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12091-8d66-7c37-8ad2-d05613eb4668;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 42358-329
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 42358-329 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42358-329 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42358-329 · Verified 2026-10-09 · open in source